Hemoglobin A1c and Immediate Postsurgical Complications Diabetes Type 2 (HbA1c)
Recruitment status was Not yet recruiting
The purpose of this study is evaluated the values of the Hemoglobin A1c previous to a surgery in patients with diabetes type II and the incidence of complication in the immediate post surgery.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Hemoglobin A1c and Immediate Postsurgical Complications Diabetes Type 2 (HbA1c)|
- Compare incidence of immediate post surgery complications in diabetic patients with HbA1c > 7 and patients with HbA1c ≤ 7 [ Time Frame: 30 days postsurgery ] [ Designated as safety issue: No ]Incidence of death, infections, cardiovascular o brainvascular disease
|Study Start Date:||July 2011|
|Estimated Study Completion Date:||July 2014|
|Estimated Primary Completion Date:||July 2014 (Final data collection date for primary outcome measure)|
|HbA1c ≤ 7|
|HbA1c > 7|
The diabetes is a increased prevalence disease in the patients that need a evaluation previous to a surgery. The best glucose control, in patients with diabetes type II, decrease the risk of microvascular complications. The patients with diabetes how pass by a cardivacular or no-cardiovascular surgery have more immediate and late complications. The most frequently complications are infection, cardiovascular events and dead.
The intensive insulinization during the cardiovascular surgery decrease the risk of a new coronary event in the immediate post surgery. There no studies that evaluated the values of Hemoglobin A1c before the surgery and the immediate post surgery complications.
A bad glicemic control had been asocieted to more number of chronic complications like diabetic neuropathy, nephropathy, retinopathy and infection disease. The Hemoglobin A1c is used like a marker of the glicemic control in the last 120 days and has a correlation with the no enzyme glicosilation. This marker could had a relation with the complication after the programmed surgery.
This study will devalued the incidence of complications in the immediate post operatory in patients with diabetes type II in relation to the hemoglobin A1c before the surgery. If the hemoglobin A1c has a correlation with the incidence of cardiovascular complications, this could made a change in the therapeutic before the programmed surgery.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01403961
|Contact: Javier Giunta, MD||+541149590200 ext firstname.lastname@example.org|
|Hospital Italiano de Buenos Aires||Not yet recruiting|
|Buenos Aires, Argentina, C1181ACH|
|Contact: Javier Giunta, MD 541149590200 ext 4419 email@example.com|
|Principal Investigator: Diego Giunta, MD|
|Principal Investigator:||Diego Giunta, MD||AIMI. HIBA.|
|Study Director:||Javier GIunta, MD||HIBA|
|Study Chair:||Carlos Bonofiglio, MD||HIBA|
|Study Chair:||Leon Litwak, MD||HIBA|